BioSpace News Archive

Micron Biomedical today announced positive Phase 1/2 data from the first-ever clinical trial of microarray technology in children including infants as young as 9 months old.

Precision Optics Corporation, Inc. (NASDAQ: POCI) today announced Dr. Joe Forkey, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2023 Investor Conference, taking place virtually on May 18, 2023.

Spanish biopharmaceutical company Biofabri, a subsidiary of Zendal, and IAVI, an international nonprofit research organization focused on developing vaccines and antibodies against infectious and neglected diseases, today announced the signing of an agreement for end-to-end development of the tuberculosis (TB) vaccine candidate MTBVAC.

The escalating battle between Claudin 6 immunotherapies from Amgen, BioNTech and Context Therapeutics, and CLDN6 antibody-drug-conjugates from Daiichi-Sankyo and TORL BioTherapeutics will be a highlight of the upcoming 2023 American Society of Clinical Oncology Annual Meeting, taking place on June 2-6, 2023, in Chicago, IL.

As part of National Women’s Health Week, Evidation and Myovant Sciences Ltd., a wholly owned subsidiary of Sumitovant Biopharma Ltd. announced results from a survey exploring the lived experiences of individuals with endometriosis and/or uterine fibroids.

Plandai Biotechnology, Inc. announce the completion of a share exchange agreement whereby PLPL shall acquire one hundred percent of the issued and outstanding ByoPlanet Interests and ByoPlanet’s fixed tangible and intangible assets in exchange for all authorized, issued, and outstanding PLPL Preferred Common Shares and Common Stock.

Researchers at Children’s Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.

Compare the Biomarket™, a groundbreaking clinical biosamples quotation platform, has officially launched today, promising researchers valuable insights into the clinical biosamples market and providing cost-effective solutions to accelerate scientific discovery. ™

The Insight Partners published latest research report on “Chronic Cough Market Size Report, Growth, Trends, Demand & Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class; Route of Administration; Distribution Channel; and Geography”,

The Insight Partners published latest research report on “CIN & HR-HPV Treatment Market Size Report, Share, Trends, Growth & Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Type, Strain Type, Offering, Product Type, and End User”, the global market size is projected to reach USD 17,164.61 million by 2028 from USD 11,635.17 million in 2022.